Copyright Reports & Markets. All rights reserved.

Global Bioengineered Skin Substitutes Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Bioengineered Skin Substitutes by Type
    • 1.3.1 Overview: Global Bioengineered Skin Substitutes Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Bioengineered Skin Substitutes Consumption Value Market Share by Type in 2023
    • 1.3.3 Allogeneic Acellular
    • 1.3.4 Xenogeneic
    • 1.3.5 Allogeneic Cells
    • 1.3.6 Autologous
  • 1.4 Global Bioengineered Skin Substitutes Market by Application
    • 1.4.1 Overview: Global Bioengineered Skin Substitutes Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Specialty Clinics
    • 1.4.4 Wound Care Centers
  • 1.5 Global Bioengineered Skin Substitutes Market Size & Forecast
  • 1.6 Global Bioengineered Skin Substitutes Market Size and Forecast by Region
    • 1.6.1 Global Bioengineered Skin Substitutes Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Bioengineered Skin Substitutes Market Size by Region, (2019-2030)
    • 1.6.3 North America Bioengineered Skin Substitutes Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Bioengineered Skin Substitutes Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Bioengineered Skin Substitutes Market Size and Prospect (2019-2030)
    • 1.6.6 South America Bioengineered Skin Substitutes Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Bioengineered Skin Substitutes Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Allergan (AbbVie)
    • 2.1.1 Allergan (AbbVie) Details
    • 2.1.2 Allergan (AbbVie) Major Business
    • 2.1.3 Allergan (AbbVie) Bioengineered Skin Substitutes Product and Solutions
    • 2.1.4 Allergan (AbbVie) Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Allergan (AbbVie) Recent Developments and Future Plans
  • 2.2 AlloSource
    • 2.2.1 AlloSource Details
    • 2.2.2 AlloSource Major Business
    • 2.2.3 AlloSource Bioengineered Skin Substitutes Product and Solutions
    • 2.2.4 AlloSource Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 AlloSource Recent Developments and Future Plans
  • 2.3 Organogenesis
    • 2.3.1 Organogenesis Details
    • 2.3.2 Organogenesis Major Business
    • 2.3.3 Organogenesis Bioengineered Skin Substitutes Product and Solutions
    • 2.3.4 Organogenesis Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Organogenesis Recent Developments and Future Plans
  • 2.4 BD
    • 2.4.1 BD Details
    • 2.4.2 BD Major Business
    • 2.4.3 BD Bioengineered Skin Substitutes Product and Solutions
    • 2.4.4 BD Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 BD Recent Developments and Future Plans
  • 2.5 Smith & Nephew
    • 2.5.1 Smith & Nephew Details
    • 2.5.2 Smith & Nephew Major Business
    • 2.5.3 Smith & Nephew Bioengineered Skin Substitutes Product and Solutions
    • 2.5.4 Smith & Nephew Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Smith & Nephew Recent Developments and Future Plans
  • 2.6 Integra LifeSciences
    • 2.6.1 Integra LifeSciences Details
    • 2.6.2 Integra LifeSciences Major Business
    • 2.6.3 Integra LifeSciences Bioengineered Skin Substitutes Product and Solutions
    • 2.6.4 Integra LifeSciences Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Integra LifeSciences Recent Developments and Future Plans
  • 2.7 Synthes (Johnson & Johnson)
    • 2.7.1 Synthes (Johnson & Johnson) Details
    • 2.7.2 Synthes (Johnson & Johnson) Major Business
    • 2.7.3 Synthes (Johnson & Johnson) Bioengineered Skin Substitutes Product and Solutions
    • 2.7.4 Synthes (Johnson & Johnson) Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Synthes (Johnson & Johnson) Recent Developments and Future Plans
  • 2.8 Axogen
    • 2.8.1 Axogen Details
    • 2.8.2 Axogen Major Business
    • 2.8.3 Axogen Bioengineered Skin Substitutes Product and Solutions
    • 2.8.4 Axogen Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Axogen Recent Developments and Future Plans
  • 2.9 Vericel Corporation
    • 2.9.1 Vericel Corporation Details
    • 2.9.2 Vericel Corporation Major Business
    • 2.9.3 Vericel Corporation Bioengineered Skin Substitutes Product and Solutions
    • 2.9.4 Vericel Corporation Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Vericel Corporation Recent Developments and Future Plans
  • 2.10 LifeNet Health
    • 2.10.1 LifeNet Health Details
    • 2.10.2 LifeNet Health Major Business
    • 2.10.3 LifeNet Health Bioengineered Skin Substitutes Product and Solutions
    • 2.10.4 LifeNet Health Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 LifeNet Health Recent Developments and Future Plans
  • 2.11 MTF Biologics
    • 2.11.1 MTF Biologics Details
    • 2.11.2 MTF Biologics Major Business
    • 2.11.3 MTF Biologics Bioengineered Skin Substitutes Product and Solutions
    • 2.11.4 MTF Biologics Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 MTF Biologics Recent Developments and Future Plans
  • 2.12 Arthrex
    • 2.12.1 Arthrex Details
    • 2.12.2 Arthrex Major Business
    • 2.12.3 Arthrex Bioengineered Skin Substitutes Product and Solutions
    • 2.12.4 Arthrex Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Arthrex Recent Developments and Future Plans
  • 2.13 Wright Medical Group NV (Stryker)
    • 2.13.1 Wright Medical Group NV (Stryker) Details
    • 2.13.2 Wright Medical Group NV (Stryker) Major Business
    • 2.13.3 Wright Medical Group NV (Stryker) Bioengineered Skin Substitutes Product and Solutions
    • 2.13.4 Wright Medical Group NV (Stryker) Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Wright Medical Group NV (Stryker) Recent Developments and Future Plans
  • 2.14 Cook Biotech Incorporated
    • 2.14.1 Cook Biotech Incorporated Details
    • 2.14.2 Cook Biotech Incorporated Major Business
    • 2.14.3 Cook Biotech Incorporated Bioengineered Skin Substitutes Product and Solutions
    • 2.14.4 Cook Biotech Incorporated Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Cook Biotech Incorporated Recent Developments and Future Plans
  • 2.15 Aroa Biosurgery
    • 2.15.1 Aroa Biosurgery Details
    • 2.15.2 Aroa Biosurgery Major Business
    • 2.15.3 Aroa Biosurgery Bioengineered Skin Substitutes Product and Solutions
    • 2.15.4 Aroa Biosurgery Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Aroa Biosurgery Recent Developments and Future Plans
  • 2.16 Surgalign Holdings
    • 2.16.1 Surgalign Holdings Details
    • 2.16.2 Surgalign Holdings Major Business
    • 2.16.3 Surgalign Holdings Bioengineered Skin Substitutes Product and Solutions
    • 2.16.4 Surgalign Holdings Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Surgalign Holdings Recent Developments and Future Plans
  • 2.17 Anika Therapeutics
    • 2.17.1 Anika Therapeutics Details
    • 2.17.2 Anika Therapeutics Major Business
    • 2.17.3 Anika Therapeutics Bioengineered Skin Substitutes Product and Solutions
    • 2.17.4 Anika Therapeutics Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Anika Therapeutics Recent Developments and Future Plans
  • 2.18 Forticell Bioscience
    • 2.18.1 Forticell Bioscience Details
    • 2.18.2 Forticell Bioscience Major Business
    • 2.18.3 Forticell Bioscience Bioengineered Skin Substitutes Product and Solutions
    • 2.18.4 Forticell Bioscience Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 Forticell Bioscience Recent Developments and Future Plans
  • 2.19 MLM Biologics
    • 2.19.1 MLM Biologics Details
    • 2.19.2 MLM Biologics Major Business
    • 2.19.3 MLM Biologics Bioengineered Skin Substitutes Product and Solutions
    • 2.19.4 MLM Biologics Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.19.5 MLM Biologics Recent Developments and Future Plans
  • 2.20 Promethean LifeSciences
    • 2.20.1 Promethean LifeSciences Details
    • 2.20.2 Promethean LifeSciences Major Business
    • 2.20.3 Promethean LifeSciences Bioengineered Skin Substitutes Product and Solutions
    • 2.20.4 Promethean LifeSciences Bioengineered Skin Substitutes Revenue, Gross Margin and Market Share (2019-2024)
    • 2.20.5 Promethean LifeSciences Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Bioengineered Skin Substitutes Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Bioengineered Skin Substitutes by Company Revenue
    • 3.2.2 Top 3 Bioengineered Skin Substitutes Players Market Share in 2023
    • 3.2.3 Top 6 Bioengineered Skin Substitutes Players Market Share in 2023
  • 3.3 Bioengineered Skin Substitutes Market: Overall Company Footprint Analysis
    • 3.3.1 Bioengineered Skin Substitutes Market: Region Footprint
    • 3.3.2 Bioengineered Skin Substitutes Market: Company Product Type Footprint
    • 3.3.3 Bioengineered Skin Substitutes Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Bioengineered Skin Substitutes Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Bioengineered Skin Substitutes Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Bioengineered Skin Substitutes Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Bioengineered Skin Substitutes Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Bioengineered Skin Substitutes Consumption Value by Type (2019-2030)
  • 6.2 North America Bioengineered Skin Substitutes Market Size by Application (2019-2030)
  • 6.3 North America Bioengineered Skin Substitutes Market Size by Country
    • 6.3.1 North America Bioengineered Skin Substitutes Consumption Value by Country (2019-2030)
    • 6.3.2 United States Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Bioengineered Skin Substitutes Consumption Value by Type (2019-2030)
  • 7.2 Europe Bioengineered Skin Substitutes Consumption Value by Application (2019-2030)
  • 7.3 Europe Bioengineered Skin Substitutes Market Size by Country
    • 7.3.1 Europe Bioengineered Skin Substitutes Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)
    • 7.3.3 France Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Bioengineered Skin Substitutes Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Bioengineered Skin Substitutes Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Bioengineered Skin Substitutes Market Size by Region
    • 8.3.1 Asia-Pacific Bioengineered Skin Substitutes Consumption Value by Region (2019-2030)
    • 8.3.2 China Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)
    • 8.3.5 India Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Bioengineered Skin Substitutes Consumption Value by Type (2019-2030)
  • 9.2 South America Bioengineered Skin Substitutes Consumption Value by Application (2019-2030)
  • 9.3 South America Bioengineered Skin Substitutes Market Size by Country
    • 9.3.1 South America Bioengineered Skin Substitutes Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Bioengineered Skin Substitutes Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Bioengineered Skin Substitutes Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Bioengineered Skin Substitutes Market Size by Country
    • 10.3.1 Middle East & Africa Bioengineered Skin Substitutes Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Bioengineered Skin Substitutes Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Bioengineered Skin Substitutes Market Drivers
  • 11.2 Bioengineered Skin Substitutes Market Restraints
  • 11.3 Bioengineered Skin Substitutes Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Bioengineered Skin Substitutes Industry Chain
  • 12.2 Bioengineered Skin Substitutes Upstream Analysis
  • 12.3 Bioengineered Skin Substitutes Midstream Analysis
  • 12.4 Bioengineered Skin Substitutes Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Bioengineered skin consists of the outer epidermis and/or dermis (the layer of skin between the epidermis and subcutaneous tissue) embedded in an acellular matrix (supporting structure) to form a biological skin substitute. Products are made from a variety of sources, including human tissue (from patients or others), non-human tissue (bovine, porcine, horse), synthetic materials (man-made), or a combination of these materials.
    According to our (Global Info Research) latest study, the global Bioengineered Skin Substitutes market size was valued at US$ 1767 million in 2023 and is forecast to a readjusted size of USD 3763 million by 2030 with a CAGR of 11.5% during review period.
    Global important companies in bioengineered skin substitutes includes Allergan (AbbVie), AlloSource, Organogenesis, and BD. The head company shares over 30% of the market. Geographically speaking, Americas holds about 50% of global market share, followed by Europe with about 35% share. Bioengineered skin substitutes includes Allogeneic Acellular, Xenogeneic, Allogeneic Cells, and Autologous. Allogeneic Acellular is the largest part of bioengineered skin substitutes industry, has a share about 80%. Other key parts include Xenogeneic who shares nearly 15% , and Autologous who shares about 5%. The application of bioengineered skin substitutes includes hospitals,specialty clinics and wound care centers. Hospitals shares the largest percent of 60.30%.
    This report is a detailed and comprehensive analysis for global Bioengineered Skin Substitutes market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Bioengineered Skin Substitutes market size and forecasts, in consumption value ($ Million), 2019-2030
    Global Bioengineered Skin Substitutes market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
    Global Bioengineered Skin Substitutes market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
    Global Bioengineered Skin Substitutes market shares of main players, in revenue ($ Million), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Bioengineered Skin Substitutes
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Bioengineered Skin Substitutes market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Allergan (AbbVie), AlloSource, Organogenesis, BD, Smith & Nephew, Integra LifeSciences, Synthes (Johnson & Johnson), Axogen, Vericel Corporation, LifeNet Health, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Bioengineered Skin Substitutes market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segmentation
    Bioengineered Skin Substitutes market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Allogeneic Acellular
    Xenogeneic
    Allogeneic Cells
    Autologous
    Market segment by Application
    Hospitals
    Specialty Clinics
    Wound Care Centers
    Market segment by players, this report covers
    Allergan (AbbVie)
    AlloSource
    Organogenesis
    BD
    Smith & Nephew
    Integra LifeSciences
    Synthes (Johnson & Johnson)
    Axogen
    Vericel Corporation
    LifeNet Health
    MTF Biologics
    Arthrex
    Wright Medical Group NV (Stryker)
    Cook Biotech Incorporated
    Aroa Biosurgery
    Surgalign Holdings
    Anika Therapeutics
    Forticell Bioscience
    MLM Biologics
    Promethean LifeSciences
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Bioengineered Skin Substitutes product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Bioengineered Skin Substitutes, with revenue, gross margin, and global market share of Bioengineered Skin Substitutes from 2019 to 2024.
    Chapter 3, the Bioengineered Skin Substitutes competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Bioengineered Skin Substitutes market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Bioengineered Skin Substitutes.
    Chapter 13, to describe Bioengineered Skin Substitutes research findings and conclusion.

    Buy now